DeliKet: Ketone drink for ICU patients on tube feeding
Part of Brain & nervous system, Mental health clinical trials.
This trial tests a special diet drink (ketone body supplement) for ICU patients who are starting tube feeding. It looks at whether the drink can help the body use energy in a different way, possibly improving recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are currently in the intensive care unit (ICU)
- You are starting or already receiving tube feeding (enteral nutrition)
- You do not have severe liver disease
- You have not had your pancreas removed and do not have insulin-dependent diabetes
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving a special ketone drink to patients in the ICU can reduce or treat delirium (confusion). If you or a loved one is in the ICU, this treatment might help clear up confusion faster.
This trial tests a special feeding schedule where ICU patients receive nutrition during the day and fast at night, which may help their recovery. It aims to see if this approach is safe and beneficial.
This trial tests a special ketone drink to see if it can help people recently hospitalized with acute heart failure feel better and recover faster. It measures how the drink affects the heart and body during the early days in the hospital.
This trial tests if not eating (fasting) during standard treatment for diabetic ketoacidosis can help patients recover faster or better. It compares the usual treatment to the same treatment without food intake.
This study looks at how a short period of fasting affects the body's immune system and metabolism in patients in the intensive care unit (ICU). It may help doctors understand how to better support patients during critical illness.
This study tests if a ketone supplement can reduce protein in urine and protect kidney function in people with chronic kidney disease or polycystic kidney disease. You drink a special supplement and researchers measure how it affects your kidneys.
Hear when a new Delirium trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.